Clinical Trial

A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.

Recruiting
View on ClinicalTrials.gov →
Summary
The transcatheter tricuspid valve clipping system is specially designed for the treatment of tricuspid regurgitation. Under the guidance of ultrasound and DSA imaging, the investigational device is advanced into the right ventricle via a femoral or jugular venous puncture approach. The clipping component grasps the edges of the dysfunctional valve leaflets (usually unable to close properly), thereby reducing the area of the tricuspid orifice that fails to coapt normally, achieving minimally invasive treatment of tricuspid regurgitation.
Trial Details
NCT Number NCT07433504
Lead Sponsor Shanghai Huihe Medical Technology Co., Ltd
Conditions Severe or Greater Tricuspid Regurgitation
Enrollment 132 participants
Start Date 2026-01-28
Primary Completion 2027-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-25